Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis

NCT04821596 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT04821596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis
Lead sponsor
University Hospital, Rouen
Phase
Not applicable
Overall status
Completed
Start date
July 13, 2020
Completion date
December 14, 2021
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis